169 related articles for article (PubMed ID: 31247726)
1. Characterization of Positional Isomers of Interchain Cysteine Linked Antibody-Drug Conjugates by High-Resolution Mass Spectrometry.
Li K; Lin ZJ; Shi H; Ma Y
Anal Chem; 2019 Jul; 91(13):8558-8563. PubMed ID: 31247726
[TBL] [Abstract][Full Text] [Related]
2. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis.
Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378
[TBL] [Abstract][Full Text] [Related]
3. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
Pan LY; Salas-Solano O; Valliere-Douglass JF
Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
[TBL] [Abstract][Full Text] [Related]
4. Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody-drug conjugates by LC-HRMS.
Li K; Zhang Z; Lin ZJ; Shi H; Ma Y
Anal Bioanal Chem; 2020 Feb; 412(4):833-840. PubMed ID: 31872274
[TBL] [Abstract][Full Text] [Related]
5. Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.
Behrens CR; Ha EH; Chinn LL; Bowers S; Probst G; Fitch-Bruhns M; Monteon J; Valdiosera A; Bermudez A; Liao-Chan S; Wong T; Melnick J; Theunissen JW; Flory MR; Houser D; Venstrom K; Levashova Z; Sauer P; Migone TS; van der Horst EH; Halcomb RL; Jackson DY
Mol Pharm; 2015 Nov; 12(11):3986-98. PubMed ID: 26393951
[TBL] [Abstract][Full Text] [Related]
6. Profiling antibody drug conjugate positional isomers: a system-of-equations approach.
Le LN; Moore JM; Ouyang J; Chen X; Nguyen MD; Galush WJ
Anal Chem; 2012 Sep; 84(17):7479-86. PubMed ID: 22913809
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
8. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
9. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
[TBL] [Abstract][Full Text] [Related]
10. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
11. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
Valliere-Douglass JF; Hengel SM; Pan LY
Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Primary Structure of Cysteine-Linked Antibody-Drug Conjugates Using Capillary Electrophoresis with Mass Spectrometry.
Saadé J; Gahoual R; Beck A; Leize-Wagner E; François YN
Methods Mol Biol; 2020; 2078():263-272. PubMed ID: 31643063
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
Huang RY; Chen G
Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
[TBL] [Abstract][Full Text] [Related]
15. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
[TBL] [Abstract][Full Text] [Related]
16. Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.
Valliere-Douglass JF; McFee WA; Salas-Solano O
Anal Chem; 2012 Mar; 84(6):2843-9. PubMed ID: 22384990
[TBL] [Abstract][Full Text] [Related]
17. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.
Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y
AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287
[TBL] [Abstract][Full Text] [Related]
18. Analytical methods for physicochemical characterization of antibody drug conjugates.
Wakankar A; Chen Y; Gokarn Y; Jacobson FS
MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation.
Guo J; Kumar S; Chipley M; Marcq O; Gupta D; Jin Z; Tomar DS; Swabowski C; Smith J; Starkey JA; Singh SK
Bioconjug Chem; 2016 Mar; 27(3):604-15. PubMed ID: 26829368
[TBL] [Abstract][Full Text] [Related]
20. Immunoprecipitation middle-up LC-MS for in vivo drug-to-antibody ratio determination for antibody-drug conjugates.
Davis JA; Kagan M; Read J; Walles M; Hatsis P
Bioanalysis; 2017 Oct; 9(20):1535-1549. PubMed ID: 29072490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
